Paulsen on Outlook for Financial Markets (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Jim Paulsen \u0010Chief Investment Strategist \u0010Wells Capital Management \u0010Will discuss the global economy, and outlook for financial markets.See omnystudio.com/listener for privacy information.
22 Elo 201610min
Patricof on Key Industry Trends (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Mark Patricof \u0010Mng Dir/Co-Head:TMT \u0010Houlihan Lokey Financial Advisors Inc \u0010Will discuss key trends in the industrySee omnystudio.com/listener for privacy information.
22 Elo 20166min
Raanes on Rollout of Cancer Treatment (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Chris A Raanes \u0010President/CEO \u0010Viewray Inc \u0010Will discuss the rollout of their cancer treatment, MRIdian, which can both image, and treat cancer patients at the same time.See omnystudio.com/listener for privacy information.
22 Elo 20166min
Stiglitz on Common Currency Threatening Europe Future (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Joseph E Stiglitz "Joe" \u0010Professor:Economics \u0010Columbia University \u0010Will discuss his new book"The Euro: How a Common Currency Threatens the Future of Europe."See omnystudio.com/listener for privacy information.
22 Elo 201610min
Nizza on Trump's Campaign Reboot (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Mike Nizza \u0010Executive Editor:BloombergPolitics.com \u0010Bloomberg Editorial \u0010Highlights the day's political news, including Donald Trump's attempt at a campaign reboot.See omnystudio.com/listener for privacy information.
22 Elo 20166min
Koons on Pfizer Agreeing to Buy Medivation (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.See omnystudio.com/listener for privacy information.
22 Elo 20166min
Kilduff on Oil Markets (Audio)
(Bloomberg) -- Taking Stock with Pimm Fox. \u0010 \u0010GUEST: \u0010John Kilduff \u0010Founding Partner \u0010Again Capital LLC \u0010Will discuss the oil markets, and whether the recent rally is sustainable.See omnystudio.com/listener for privacy information.
19 Elo 20166min
Dolfi on Investment in Fashion & Lifestyle (Audio)
(Bloomberg) -- Taking Stock with Pimm Fox.\u0010\u0010GUEST:\u0010Martin Dolfi\u0010Managing Partner\u0010M3 Ventures\u0010Will discuss investment opportunities in the fashion and lifestyle space.See omnystudio.com/listener for privacy information.
19 Elo 201610min
